Literature DB >> 26441016

The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides.

Sadanori Furudate1, Taku Fujimura1, Aya Kakizaki1, Yumi Kambayashi1, Masayuki Asano1, Akiko Watabe1, Setsuya Aiba1.   

Abstract

Mycosis fungoides (MF) starts as an indolent disease, progresses from a patch stage to confluent plaques and ultimately develops skin tumors. Tumor-associated macrophages (TAMs) play roles in maintaining the tumor microenvironment in MF. The purpose of this study was to elucidate the involvement of TAMs in the lesional skin of different stages of MF. First, we immunohistologically examined the percentage of CD163+ macrophages and CD206+ cells, as well as the levels of periostin and IL-4 in cancer stroma. The percentage of CD206+ cells increased in parallel with tumor progression, while there was no significant difference in the percentage of CD163+ cells. Periostin was prominent in the stromal area at the patch and plaque stages but decreased at the tumor stage. In contrast, IL-4 was prominently stained at both plaque and tumor stages. To further elucidate the molecular mechanisms of the effects of these stromal factors on TAMs, we examined their effects on mRNA expression in monocyte-derived macrophages in vitro. Based on microarray analysis and gene ontology, we examined a series of chemokines and MMPs whose expression was strongly connected with periostin stimulation. The DNA microarray results were verified in M2 macrophages using real-time PCR. We further examined the mRNA expression of these chemokines and MMPs in the presence of periostin and IL-4 to simulate the advanced stages of MF and validated their protein expression by ELISA. Our present report suggests possible roles of periostin on TAMs in establishing the tumor microenvironment in MF.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  chemokines; mycosis fungoides; periostin; tumor-associated macrophages (TAMs)

Mesh:

Substances:

Year:  2015        PMID: 26441016     DOI: 10.1111/exd.12873

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  29 in total

1.  Highly cytotoxic natural killer cells are associated with poor prognosis in patients with cutaneous T-cell lymphoma.

Authors:  Bethany Mundy-Bosse; Nathan Denlinger; Eric McLaughlin; Nitin Chakravarti; Susan Hwang; Li Chen; Hsiaoyin Charlene Mao; David Kline; Youssef Youssef; Rebecca Kohnken; Dean Anthony Lee; Gerard Lozanski; Aharon G Freud; Pierluigi Porcu; Basem William; Michael A Caligiuri; Anjali Mishra
Journal:  Blood Adv       Date:  2018-08-14

Review 2.  Periostin in the pathogenesis of skin diseases.

Authors:  Hiroyuki Murota; Yang Lingli; Ichiro Katayama
Journal:  Cell Mol Life Sci       Date:  2017-09-15       Impact factor: 9.261

3.  Genome-wide transcriptome analysis of the STAT6-regulated genes in advanced-stage cutaneous T-cell lymphoma.

Authors:  Alyxzandria M Gaydosik; Dawn S Queen; Megan H Trager; Oleg E Akilov; Larisa J Geskin; Patrizia Fuschiotti
Journal:  Blood       Date:  2020-10-08       Impact factor: 22.113

4.  Immune signatures of CD4 and CD68 predicts disease progression in cutaneous T cell lymphoma.

Authors:  Sanling Huang; Mengying Liao; Siliang Chen; Ping Zhang; Fangzhou Xu; Hongyu Zhang
Journal:  Am J Transl Res       Date:  2022-05-15       Impact factor: 3.940

5.  Dermal fibroblasts promote cancer cell proliferation and exhibit fibronectin overexpression in early mycosis fungoides.

Authors:  Burcu Beksaç; Laura Gleason; Sarah Baik; John M Ringe; Pierluigi Porcu; Neda Nikbakht
Journal:  J Dermatol Sci       Date:  2022-03-14       Impact factor: 5.408

6.  M2-Polarized Macrophages Compose Lupus Vulgaris Arising from a Bacillus Calmette-Guérin Vaccination Site.

Authors:  Yota Sato; Taku Fujimura; Sadanori Furudate; Aya Kakizaki; Osamu Iizawa; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2016-07-19

7.  Plexiform Fibrohistiocytic Tumor on the Ear: Case Report and Immunohistochemical Investigation of Stromal Factor.

Authors:  Kosuke Shido; Taku Fujimura; Aya Kakizaki; Sadanori Furudate; Masayuki Asano; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2016-02-05

8.  Periostin in the Cancer Stroma of Mycosis Fungoides Palmaris et Plantaris: A Case Report and Immunohistochemical Study.

Authors:  Kayo Tanita; Taku Fujimura; Aya Kakizaki; Sadanori Furudate; Masato Mizuashi; Akiko Watabe; Setsuya Aiba
Journal:  Case Rep Dermatol       Date:  2016-02-06

Review 9.  Tumor-Associated Macrophages: Therapeutic Targets for Skin Cancer.

Authors:  Taku Fujimura; Yumi Kambayashi; Yasuhiro Fujisawa; Takanori Hidaka; Setsuya Aiba
Journal:  Front Oncol       Date:  2018-01-23       Impact factor: 6.244

10.  Phase I study of nivolumab combined with IFN-β for patients with advanced melanoma.

Authors:  Taku Fujimura; Takanori Hidaka; Yumi Kambayashi; Sadanori Furudate; Aya Kakizaki; Hisayuki Tono; Akira Tsukada; Takahiro Haga; Akira Hashimoto; Ryo Morimoto; Takuhiro Yamaguchi; Tadao Takano; Setsuya Aiba
Journal:  Oncotarget       Date:  2017-04-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.